Swine flu could kill 90,000 in the U.S.: White House report

August 25, 2009 02:28 pm | Updated November 17, 2021 06:52 am IST - Washington

Technicians perform production operations in the new influenza manufacturing facility in the U.S. French drugmaker Sanofi Pasteur began human trials of its swine flu vaccine in about 2,000 people in the U.S. becoming the third company conducting clinical trials on swine flu vaccines. Photo: AP

Technicians perform production operations in the new influenza manufacturing facility in the U.S. French drugmaker Sanofi Pasteur began human trials of its swine flu vaccine in about 2,000 people in the U.S. becoming the third company conducting clinical trials on swine flu vaccines. Photo: AP

There are possibilities that the A(H1N1) flu could engulf a large part of the U.S. ending up in hospitalising two million people this winter and killing as much as 90,000 in the country, a White House report said today.

“By the end of 2009, 60 to 120 million Americans would have experienced symptomatic infection with 2009—H1N1; nearly one to two million would have been hospitalised, with about 150,000—300,000 cared for in intensive care units (ICUs); and somewhere between 30,000 and 90,000 people would have died, the majority of them under 50 years of age,” said the report ‘On US Preparations for 2009-H1N1 Influenza’

Overall, 20 per cent to 40 per cent of the population could develop symptoms of the strain commonly known as swine flu. During a normal flu season, the virus kills about 35,000 Americans.

However, the authors of the report released by the President’s Council of Advisors on Science and Technology said this was one of the possibilities and not a prediction.

“We emphasise that this is a plausible scenario, not a prediction. By way of comparison, it is less severe by a factor of three (in terms of expected deaths per capita) than the ‘reasonable worst case’ planning assumptions, publicised by the UK government, for the H1N1 resurgence in that country,” the report said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.